PhaseBio Pharmaceuticals | NT 10-K: Others
Apr 3 04:24
PhaseBio Pharmaceuticals | 8-K: Current report
Mar 13 04:40
PhaseBio Pharmaceuticals | 8-K: Current report
Nov 30, 2023 05:55
PhaseBio Pharmaceuticals | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Nov 16, 2023 05:17
PhaseBio Pharmaceuticals | 8-K: Current report
Oct 3, 2023 19:17
PhaseBio Pharmaceuticals | 8-K: Current report
Sep 27, 2023 20:52
PhaseBio Pharmaceuticals | 8-K: Current report
Aug 26, 2023 00:34
PhaseBio Pharmaceuticals | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Aug 26, 2023 00:31
PhaseBio Pharmaceuticals | 8-K: Current report
Jul 1, 2023 04:21
PhaseBio Pharmaceuticals | 8-K: Current report
May 31, 2023 04:02
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director van den Broek Richard
May 20, 2023 04:18
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Thorp Clay
May 20, 2023 04:18
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Humphries William D.
May 20, 2023 04:18
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HARRIGAN EDMUND
May 20, 2023 04:17
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sapir Alex
May 20, 2023 04:17
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Loewy Caroline M
May 20, 2023 04:16
PhaseBio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hutson Nancy J
May 20, 2023 04:15
PhaseBio Pharmaceuticals | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
May 17, 2023 04:23
PhaseBio Pharmaceuticals | 8-K: Current report
May 10, 2023 20:08
PhaseBio Pharmaceuticals | NT 10-K: Others
Apr 4, 2023 04:05
No Data
No Data